Metabolomic and transcriptomic response to imatinib treatment of gastrointestinal stromal tumour in xenograft-bearing mice

伊马替尼 间质细胞 转录组 癌症研究 医学 代谢组学 主旨 肿瘤科 生物信息学 生物 基因 生物化学 基因表达 髓系白血病
作者
Szymon Macioszek,Danuta Dudzik,Rafał Bartoszewski,Tomasz Stokowy,Diether Lambrechts,Bram Boeckx,Agnieszka Woźniak,Patrick Schöffski,Michał Jan Markuszewski
出处
期刊:Translational Oncology [Elsevier BV]
卷期号:30: 101632-101632 被引量:7
标识
DOI:10.1016/j.tranon.2023.101632
摘要

BACKGROUND: Although imatinib is a well-established first-line drug for treating a vast majority of gastrointestinal stromal tumours (GIST), GISTs acquire secondary resistance during therapy. Multi-omics approaches provide an integrated perspective to empower the development of personalised therapies through a better understanding of functional biology underlying the disease and molecular-driven selection of the best-targeted individualised therapy. In this study, we applied integrative metabolomic and transcriptomic analyses to elucidate tumour biochemical processes affected by imatinib treatment. MATERIALS AND METHODS: A GIST xenograft mouse model was used in the study, including 10 mice treated with imatinib and 10 non-treated controls. Metabolites in tumour extracts were analysed using gas chromatography coupled with mass spectrometry (GC-MS). RNA sequencing was also performed on the samples subset (n=6). RESULTS: Metabolomic analysis revealed 21 differentiating metabolites, whereas next-generation RNA sequencing data analysis resulted in 531 differentially expressed genes. Imatinib significantly changed the profile of metabolites associated mainly with purine and pyrimidine metabolism, butanoate metabolism, as well as alanine, aspartate, and glutamate metabolism. The related changes in transcriptomic profiles included genes involved in kinase activity and immune responses, as well as supported its impact on the purine biosynthesis pathway. CONCLUSIONS: Our multi-omics study confirmed previously known pathways involved in imatinib anticancer activity as well as correlated imatinib-relevant downregulation of expression of purine biosynthesis pathway genes with the reduction of respectful metabolites. Furthermore, considering the importance of the purine biosynthesis pathway for cancer proliferation, we identified a potentially novel mechanism for the anti-tumour activity of imatinib. Based on the results, we hypothesise metabolic modulations aiming at the reduction in purine and pyrimidine pool may ensure higher imatinib efficacy or re-sensitise imatinib-resistant tumours.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
zzz完成签到,获得积分10
刚刚
1秒前
1秒前
科研通AI6.4的应助被全或无采纳,获得20
1秒前
2秒前
Hiker发布了新的文献求助10
2秒前
哈嘿呦发布了新的文献求助10
2秒前
可爱的函函的应助被cell采纳,获得10
2秒前
fx发布了新的文献求助10
3秒前
科研通AI6.3的应助被无糖零脂采纳,获得10
3秒前
搜集达人的应助被Bio采纳,获得10
4秒前
4秒前
清爽的天晴完成签到,获得积分10
5秒前
5秒前
5秒前
6秒前
叫滚滚发布了新的文献求助10
6秒前
香蕉觅云的应助被标致青雪采纳,获得10
7秒前
xin完成签到,获得积分10
7秒前
7秒前
7秒前
8秒前
9秒前
万能图书馆的应助被全或无采纳,获得20
9秒前
fangxiang发布了新的文献求助10
9秒前
Orange的应助被热情的远锋采纳,获得10
9秒前
珍珠发布了新的文献求助10
9秒前
10秒前
10秒前
来路生云烟完成签到 ,获得积分10
10秒前
10秒前
8R60d8的应助被Plus是只喵采纳,获得10
11秒前
11秒前
TRY关闭了TRY的文献求助
12秒前
13秒前
13秒前
Gaara0504发布了新的文献求助10
13秒前
科研通AI6.2的应助被Sissi采纳,获得30
13秒前
领导范儿的应助被正直的西牛采纳,获得10
13秒前
14秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Improving the wear resistance of vehicle gear oil by oil soluble LaF3 nanoparticles and typical additives of gear oil 500
Boundaries and Bodhisattvas 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8183241
求助须知:如何正确求助?哪些是违规求助? 9572493
关于积分的说明 21826218
捐赠科研通 7780115
什么是DOI,文献DOI怎么找? 3433982
关于科研通互助平台的介绍 2558103
邀请新用户注册赠送积分活动 2480192